These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38128610)

  • 1. Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass.
    Cristoferi I; Varol H; van Baardwijk M; Rahiem L; Lila KA; van den Bosch TPP; Baan CC; Hesselink DA; Kramann R; Minnee RC; Mustafa DAM; Reinders MEJ; Roelen DL; Shahzad-Arshad SP; Smith RN; Stubbs AP; Colvin RB; Rosales IA; Clahsen-van Groningen MC
    Kidney Int; 2024 Apr; 105(4):812-823. PubMed ID: 38128610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
    Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation.
    Parajuli S; Redfield RR; Garg N; Aziz F; Mohamed M; Astor BC; Zhong W; Djamali A; Mandelbrot DA
    Transplantation; 2019 Jul; 103(7):1468-1476. PubMed ID: 30335696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury.
    Teixeira AC; Távora F; de Deus E Silva MLF; Prado RMG; de Matos Esmeraldo R; de Sandes-Freitas TV
    Clin Exp Nephrol; 2021 Mar; 25(3):305-314. PubMed ID: 33242156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E
    Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
    Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation.
    Nankivell BJ; Taverniti A; Viswanathan S; Ronquillo J; Carroll R; Sharma A
    Am J Transplant; 2024 Jul; ():. PubMed ID: 39084463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody.
    Lubetzky M; Hayde N; Ó Broin P; Ajaimy M; Bao Y; Mohammed O; Schwartz D; Pullman J; Akalin E
    Clin Transplant; 2019 Mar; 33(3):e13469. PubMed ID: 30578675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
    Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
    Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of transplant glomerulopathy early after kidney transplantation.
    Shimizu T; Ishida H; Tanabe T; Shirakawa H; Tanabe K; Honda K; Koike J
    Clin Transplant; 2011 Jul; 25 Suppl 23():34-8. PubMed ID: 21623912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Iida S; Tanabe K; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).
    Loupy A; Hill GS; Suberbielle C; Charron D; Anglicheau D; Zuber J; Timsit MO; Duong JP; Bruneval P; Vernerey D; Empana JP; Jouven X; Nochy D; Legendre CH
    Am J Transplant; 2011 Jan; 11(1):56-65. PubMed ID: 21199348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular C4d Immunoperoxidase in Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.
    Nankivell BJ; P'Ng CH; Shingde M
    Kidney Int Rep; 2022 Jul; 7(7):1594-1607. PubMed ID: 35812271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of C4d deposition in antibody-mediated rejection.
    Takeda A; Otsuka Y; Horike K; Inaguma D; Hiramitsu T; Yamamoto T; Nanmoku K; Goto N; Watarai Y; Uchida K; Morozumi K; Kobayashi T
    Clin Transplant; 2012 Jul; 26 Suppl 24():43-8. PubMed ID: 22747475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy.
    Sijpkens YW; Joosten SA; Wong MC; Dekker FW; Benediktsson H; Bajema IM; Bruijn JA; Paul LC
    Kidney Int; 2004 Jun; 65(6):2409-18. PubMed ID: 15149354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.